Clinical Trial Update: Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy [NA]

View source ↗

Summary

This clinical trial update assesses the efficacy and safety of a first-line antiretroviral regimen—tenofovir disoproxil fumarate, lamivudine, and efavirenz—for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Sustiva (efavirenz)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Peking Union Medical College | Conditions: AIDS/HIV PROBLEM | NA | Status: UNKNOWN